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Background: In vitro digestion models show great promise in facilitating the rationale design of foods.
This paper provides a look into the current state of the art and outlines possible future paths for de-
velopments of digestion models recreating the diverse physiological conditions of speciﬁc groups of the
human population.
Scope and approach: Based on a collective effort of experts, this paper outlines considerations and pa-
rameters needed for development of new in vitro digestion models, e.g. gastric pH, enzymatic activities,
gastric emptying rate and more. These and other parameters are detrimental to the adequate develop-
ment of in vitro models that enable deeper insight into matters of food luminal breakdown as well as
nutrient and nutraceutical bioaccessibility. Subsequently, we present an overview of some new and
emerging in vitro digestion models mirroring the gastro-intestinal conditions of infants, the elderly and
patients of cystic ﬁbrosis or gastric bypass surgery.
Key ﬁndings and conclusions: This paper calls for synchronization, harmonization and validation of po-
tential developments in in vitro digestion models that would greatly facilitate manufacturing of foods
tailored or even personalized, to a certain extent, to various strata of the human population.
© 2016 Elsevier Ltd. All rights reserved.n Federation of Food Science
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ro digestion; PTL, Pancreatic
y of Foods and Bioactives,
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mes).1. Introduction
1.1. In vitro models for food research
In vitro digestion (IVD) modelling is a vivid ﬁeld of research that
shows great promise in facilitating the development of foods and
oral formulations based on better understanding of their digestive
fate in the stomach and small intestine in as well as downstream
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& Bakalis, 2016; Guerra et al., 2012; Hur, Lim, Decker, &
McClements, 2011; Payne, Zihler, Chassard, & Lacroix, 2012).
Although human or in vivo animal studies are still considered a
“gold standard” for tackling issues of bioaccessibility, absorption,
bioavailability, metabolism and excretion, IVD methods have the
advantage of being more rapid, less labor intensive and having
signiﬁcantly less bioethical restrictions. In fact, various IVD models
have been increasingly applied to assess the digestive fate and
potential toxicity of ingested natural and engineered nano-mate-
rials (Lefebvre et al., 2015). This has led to great variability in sci-
entiﬁc efforts, including some contradicting studies, and stimulated
the recent effort of the INFOGEST network of scientists to develop a
consensus harmonized static in vitro digestion model based on
physiologically relevant conditions gathered from humans
(Minekus et al., 2014). This harmonized protocol was validated in a
wide inter-laboratory trial (Egger et al., 2016) and is currently
pending on-going efforts to correlate ﬁndings of protein di-
gestibility with an in vivo trial in pigs and biochemical assays with
human aspirates (yet to be published). However, these and other
numerous scientiﬁc publications focus on IVD systems designed for
evaluating the digestive fate of foods and oral formulations in the
adult alimentary canal.
During a dedicated workshop held by the European Federation
of Food Science and Technology (EFFoST) in Athens on November
2015, we found that current physiological literature offers pro-
fessionals additional opportunities to recreate the unique and
speciﬁc gastro-intestinal (GI) functions of other human pop-
ulations, such as infants, the elderly and more. Such intriguing
possibilities would open new opportunities to study and develop
foods and oral formulations better tailored to the needs of such
speciﬁc populations. Based on the pooled and accumulated expe-
rience of the INFOGEST network, it was decided to help a system-
atic and responsible orchestration of relevant global efforts,
maximize synergisms between researchers and harmonize efforts
to develop new IVD models. Thus, this paper provides a look into
the current state of the art and paves possible future paths for
developments, all with the aim of ensuring adequate and fruitful
endeavors and outputs to the food and health community.
1.2. Current status of adult in vitro digestion (IVD) models
In vitro digestion models were initially developed to serve as
research tools to characterize and clarify the structural and
biochemical changes of food components under physiological
conditions, caused by alimentary enzymes (Romano et al., 2016), GI
motility and by the colonic microbiota. In principle, IVD models of
the upper GI need to overcome the shortcomings of in vivo trials (i.e.
ethical constraints, low throughput, control over subjects and
reproducibility) and account for the most bio-relevant anatomical
and physiological considerations mirroring the mouth, stomach,
small and large intestine lumen and gut lining. In fact and in spite of
their limitations, IVD models are particularly suited for investi-
gating the luminal physiochemical changes in food, matters of
bioaccessibility and some aspects of bioavailability.
Historically, efforts to develop IVD models began in the early
1990's with pioneering works to develop reliable, robust, repro-
ducible and bio-relevant tools like the multi-compartmental GI
model developed by TNO in the Netherlands (Minekus, Marteau,
Havenaar, & Huisintveld, 1995) or the three stage continuous
fermentation systems recreating the human colon (Macfarlane,
Macfarlane, & Gibson, 1998; Molly, Woestyne, & Verstraete,
1993). Since, the ﬁeld has boomed with numerous IVD models,
ranging from simple static mono-compartmental models to
computer-controlled multi-compartmental dynamic IVD models,as reviewed by others (Glahn, Wien, VanCampen, & Miller, 1996;
Guerra et al., 2012; Hur et al., 2011; McClements & Li, 2010;
Payne et al., 2012; Yoo & Chen, 2006). Recent studies even raised
the possibility of using human GI aspirates in IVD models (Ulleberg
et al., 2011) or coupling IVD models with human cell cultures of
Caco-2 epithelial cells or Caco-2 co-cultures with HT-29 mucus
producing cells (Deat et al., 2009; Vors et al., 2012). Yet, the low
accessibility and stability of human aspirates and the complexity of
coupling IVD research with cell cultures, challenge the wide spread
use of highly bio-relevant alternatives over simple protocols
currently used in IVD models. Further, in vitro cell culture systems
have been coupled to some IVD models to enable investigating
questions of cellular uptake and brush border enzymatic break-
down, which better elucidate the bioavailability of speciﬁc sub-
stances (Deat et al., 2009; Manione et al., 2015; Vors et al., 2012).
Concomitantly, various efforts reported to develop and apply
sophisticated IVD models that are intended to be more realistic,
encompassing various aspects of digestion dynamics (e.g. physio-
logical acid secretion and gastric emptying), mass transport phe-
nomena (i.e. absorption and diffusion) and rheological aspects (i.e.
mixing) (Blanquet et al., 2004; Dekkers, Kolodziejczyk,
Acquistapace, Engmann, & Wooster, 2016; Kong & Singh, 2010a;
Levi & Lesmes, 2014; Mercuri, Lo Curto, Wickham, Craig, &
Barker, 2008; Shani-Levi, Levi-Tal, & Lesmes, 2013; Tharakan,
Norton, Fryer, & Bakalis, 2010; Yoo & Chen, 2006). To date, both
advanced and simple IVD models have be used to investigate a
variety of systems. Examples include investigations of simple high
purity protein solutions, multi-component model systems like
emulsions and evenmore real foods, like dairy gels and pasta. These
and other investigations have signiﬁcantly advanced our under-
standing of the interplay between food ingredients, food products
and the alimentary canal of healthy adults. Such insights include
not just understanding of food breakdown but also its impact on
gastro-intestinal functions, e.g. gastric emptying and intestinal
motility, as detailed by others (Grundy et al., 2016; Houghton,
Hickson, & Read, 1987; Meyer, Elashoff, & Lake, 1999; Sarosiek
et al., 2010).
1.2.1. Identiﬁed research needs
Despite the various hectic activity in the ﬁeld of understanding
food's digestion in adults, there is still much room for further ad-
vancements and breaching of current gaps in knowledge and ca-
pabilities. The various discussions held during the Athens
workshop identiﬁed that amongst future advancements in the
ﬁeld, research should include efforts: [I] To improve the bio-
relevance of luminal composition and dynamics (e.g. pH proﬁles
and use of gastric lipases); [II] To validate and/or correlate IVD data
with in vivo ﬁndings; [III] To recreate the 3D micro-architecture of
the intestinal lining and mucosa through co-cultures (e.g. Caco-2
and HT29 cell lines, grown on various scaffolds); and [IV] To
develop predictive in silico models. All of these topics were
enthusiastically discussed in separate work groups during the
workshop and are expected to bring up further scientiﬁc
publications.
1.3. Rationale and approach for extending IVD models
Advancements in the ﬁeld of food science and technology need
to address numerous challenges that humanity is and will be facing
in the 21st century (Floros et al., 2010). These challenges will
include feeding the growing and ageing world population, better
and sustainable use of natural resources as well as improving our
ability to exploit foods' potential to prevent diseases and maintain
health promote wellness. In this respect, personalized or tailored
nutrition seem highly promising and challenging strategies (Joost
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bridging manufacturing capabilities and product engineering to
meet the speciﬁc needs of the consumer. Based on the demon-
strated success in the ﬁeld of infant formula development, IVD
models harbor great potential to facilitate relevant developments of
foods tailored to thespeciﬁc GI capabilities of speciﬁc human starta
such as elderly people, pregnant women, patients of various In-
ﬂammatory Bowel Diseases (IBD) and even diabetics.
Thus, this paper outlines the considerations and parameters
needed for development of new IVD models as well as an overview
of some of the new and emerging IVD models and the relevant
physiological information, all with the aim of stimulating adequate
and fruitful endeavors and outputs to the food and health com-
munity. Adapting the consensus INFOGEST protocol scheme, a basic
static model is suggested to comprise of an oral, gastric and in-
testinal phase (Minekus et al., 2014). Each phase should address the
composition of the relevant simulated ﬂuid (ionic and enzymatic
composition), the time of processing and the nature of the bolus/
chyme (liquid, semi-solid or solid and dilution ratio with the bodily
secretions). The selection of the quantitative aspects for the oper-
ational parameters should rely on information gathered from the
most relevant human studies with good statistical power (i.e.
avoiding studies with less than 10 subjects as a rule of thumb). In
circumstances where no human data can be found, developers
should either make their best effort to rationally approximate the
values or attempt to determine them directly as a part of a human
trial. Thus, any new IVDmodel should clearly deﬁne its parameters,
justify their selection and support it with relevant references.
2. Practical considerations for developing IVD models
Human GI physiology is a complicated semi-continuous set of
bioreactors that are intertwined with the hematological, hormonal
and nervous systems and change during life (Johnson, 2007;
Remond et al., 2015; Tortora & Derrickson, 2011). This highly
complex nature of the GI limits the ability to recreate its entire
functions in an in vitro model. However, many aspects of luminal
digestion can be mirrored in IVDmodels using reliable and detailed
information on the digestive system that can be found in the sci-
entiﬁc literature. Therefore, it is imperative to understand the
limitations of each model and ensure they do not collide with the
research hypotheses. To this end, it is also imperative to be aware of
and address the key anatomical and physiological parameters of the
relevant GI organs.
The process of food digestion is an orchestrated series of bio-
processing operations that involve the breakdown of food, the
release of nutrients, their uptake or downstream fermentation
before their ultimate removal from the body through defecation.
During digestion in the upper GI, food structure is broken down in
the mouth, stomach and small intestine through complex reactions
and interactions involving chemical and mechanical processes
(Ferrua & Singh, 2010; Johnson, 2007; Sensoy, 2014). Therefore, the
following section discuss the most critical physiological parameters
that are essential for in vitro digestion models.
2.1. Oral phase
Oral processing involves mastication and mechanical break-
down of food into a soft mass, termed bolus which is a mixture of
processed food and saliva (DeSesso & Jacobson, 2001). This short
phase is detrimental to the sensorial perception of food and can be
viewed as a coarse mechanical processing step with little chemical
changes (Aken, Vingerhoeds, &Wijk, 2011; van Vliet, van Aken, de
Jongh, & Hamer, 2009). This ﬁrst step of digestion involves mixing
foodwith salivary ﬂuid that contains about 99%water in addition tovarious electrolytes and proteins, including enzymes such as
amylase (Aps & Martens, 2005; Rantonen, 2003). Saliva is contin-
uously secreted into the oral cavity by parasympathetic control.
While resting, the ﬂow rate is about 0.5 ml/min; but upon stimu-
lation, the secretion increases 3 to 4- fold with maximal ﬂow rates
of 10 ml/min (Guyton, 1991). Healthy adults will produce
500e1500 ml saliva per day (Aps & Martens, 2005). Salivary ﬂuid
composition depends on the ﬂow rate: at higher ﬂow rates, sodium,
calcium, chloride, bicarbonate, amylase increase while phosphate
and mucin concentrations decrease, and the potassium concen-
trations show little change. Salivary pH values also ﬂuctuate be-
tween fasted to fed state with values of 6.2e7.4 to 7.4e7.6,
respectively (Versantvoort, Van de Kamp, & Rompelberg, 2004).
The key salivary enzyme is a-amylase that hydrolyzes starch and
related a-(1,4)-linked polysaccharides (Nagler & Hershkovich,
2005; Shern, Fox, & Li, 1993). Mucin is also an important compo-
nent of saliva with studies indicating it to induce emulsion ﬂoc-
culation (Sarkar, Goh, & Singh, 2010, 2009; Singh & Ye, 2013;
Vingerhoeds, Silletti, de Groot, Schipper, & van Aken, 2009). Yet,
commercial mucins are partially hydrolyzed mixtures of mamma-
lian mucins which limit their bio-relevance when applied in IVD
models. In addition, there is some debate on the possible existence
and activity of lingual lipase with a report indicating lingual lipase
is active between pH 2e6.4, indicating that this enzyme is active
from the mouth to the small intestine (Hamosh, 1994).
2.2. Gastric phase
Following bolus formation in the oral phase, the stomach further
processes the bolus into a semi-solid chyme within four distinct
regions: cardiac, fundic, body and the pyloric regions (Ferrua &
Singh, 2010; Kong & Singh, 2010b). Gastric juice comprises of hy-
drochloric acid, enzymes (pepsin and gastric lipase), various elec-
trolytes, mucus, intrinsic factor and hormones with approximately
2 L of gastric juice secreted daily and 0.7 L secreted after a typical
meal (Kopf-Bolanz et al., 2012; Seeley, Stephens, & Tate, 1992).
Parietal cells lining the stomach wall are responsible for the
secretion of hydrochloric acid into the gastric lumen and bicar-
bonate into the bloodstream. The activity of these cells is respon-
sible for the unique pH of the stomach which dynamically changes
during digestion from 1.5 to 2.0 in the fasted state to 3.0e7.0 in the
fed state. Gastric acidity induces protein denaturation and precip-
itation, hydrolytic reactions (e.g. breakdown of starch) and signif-
icantly reduces bacterial counts in the gastric lumen. The post-
prandial pH rise in the stomach is attributed to the buffering ca-
pacity of the ingested food and the Parietal cells generate a pH
gradient that over the course of time reverts luminal pH back to the
fasted state values. The pH proﬁles depend on age and clinical
conditions of the consumer (Table 1) and can have various ramiﬁ-
cations to the properties of ingested food systems, such as emul-
sions and gels (Dekkers et al., 2016; Shani-Levi et al., 2013). Gastric
lipolysis and proteolysis are tightly linked (Guyton, 1991; Sams,
Paume, Giallo, & Carriere, 2016). The key gastric proteolytic
enzyme, pepsin, is activated from its precursor pepsinogen
(secreted by chief cells) via acid hydrolysis. The activated enzyme,
which is also equated with commercial porcine pepsin, has a wide
range of activity with optimal activity at pH 2 and inactivate just
above pH 6.5 (Johnston, Dettmar, Bishwokarma, Lively, & Koufman,
2007). Pepsin is a non-speciﬁc protease and therefore hydrolyses
itself (a reaction termed auto-pepsinolysis) and other enzymes
present in the lumen. Another gastric enzyme is gastric lipase
which is also activated by the acidic environment in the stomach
(Sams et al., 2016). Gastric lipase presents sn-3 regiospeciﬁcity thus
it hydrolyses triglycerides into sn-1,2diglycerides and one free fatty
acid, pancreatic triglyceride lipase colipase dependent which is sn-
Table 1
Physiological characterization of human gastro-intestinal ﬂuids.
Fasted Fed Suggested references
Oral phase
pH 6; 6.2e7.4 7; 7.4e7.6 Guyton, 1991; Versantvoort, 2004
Fluid output 0.5 mL/h 10 mL per meal Guyton, 1991
Amylase
Lipase
45.6e49.6 (U/mL)
0.60e0.68 (U/mL)
43.7e47.5 (U/mL)
0.27e0.39 (U/mL)
Neyraud, 2012
Neyraud, 2012
Transit time of meal e 10 sece2 min Guerra, 2012
Gastric phase
pH 1.5e2.0 3.0e7.0 Roberts, 2006; Malagelada, 1976
Fluid output 1e85 mL 238 mL Roberts, 2006; Hunt, 1951
Pepsin
Gastric lipase
0e8335 (U/mL)
120e130 (U/mL)
22,000e24,000 (U/mL) Janowitz, 1952; Hunt, 1951
Sams, 2016
Transit time of meal e 15 mine3 h Guerra, 2012
Small intestine
pH 5.4e6.5 5.5e7.5 Dressman 1990; Ekmekcioglu 2002
Bicarbonate sectretion 15e27 mM/h Ogden, 1993
Total ﬂuid output 118 mL/h
20e160 mL
9000 mL/24 h (Mean 5250 mL)
60e320 mL/3e4 h
200e300 mL/4 h
Ekmekcioglu, 2002
Gotch, 1957
Ogden, 1993
Total proteolytic activity
Trypsin output
Trypsin activity
Chymotrypsin output
Amylase output
Amylase activity
Lipase output
Lipase activity
5.6e25.4 U/mL
50e100e500 U/mL
33e77 IU/mL
70e150 U/Kg bodyweight/15 min
500e1000 (U/mL)
97e450 (IU/mL)
3000e6000 (U/ml)
100e400 (IU/ml)
234e524 (IU/ml)
Ulleberg, 2011; Krogdahl & Holm, 1979
Keller & Layer, 2005
Braganza, 1978
Holtmann, 1996
Keller & Layer, 2005
Braganza, 1978
Keller & Layer, 2005
Keller & Layer, 2005
Braganza, 1978
Bile (TDCa, GCb, GCDCc, GDCd) 1e4.5 mM
5.8e39 uM/ml
2.2e11.2 mM
Ulleberg, 2011
Fausa, 1974
Surface tension 32.3 mN/m 28 mN/m Kalantzi, 2006
Transit time 2e5 h Kalantzi, 2006
Large intestine
pH 6.4e7.0 Evans, 1988
Bacterial load 1  1011e1012 CFU/g material Evans, 1988
Short chain fatty acids 125e139 mM Cummings, 1987
Total ﬂuid volume 187 mL Cummings, 1990
Transit time 12e24 h Guerra, 2012
a Taurodeoxycholate.
b Glycocholate.
c Glycochenodeoxycholate.
d Glycodeoxycholate.
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gastric lipase is hard to ﬁnd and is currently neglected in many IVD
models, thought it initiates lipolysis and release free fatty acids
which activate pancreatic triglyceride lipase.
The pyloric sphincter controls gastric emptying into the small
intestine and is affected by three major factors: volume of the meal,
its osmotic pressure and caloric content. Approximately 2 kcal/per
minute are delivered through the pylorus to the duodenum
(Campbell, 2015; Sams et al., 2016). Furthermore, gastric emptying
has beenwell described by the Elashoff equation (Elashoff, Reedy,&
Meyer, 1982).
2.3. Small intestinal phase
Gastric chyme is gradually emptied into the small intestine,
where most of the chemical breakdown and absorption occur
mediated by auxiliary secretions of the liver, gall bladder, pancreas
and intestinal epithelia. Chyme entering from the stomach to the
small intestine are neutralized using bicarbonate and the pH in-
creases from 2 to 6.2 in the duodenum, which is the ﬁrst segment of
the small intestine (Kalantzi et al., 2006). The main degradation of
food starts in the duodenum into which about 1.2e1.5 L of
pancreatic juice is secreted daily (Johnson, 2007). The jejunum and
ileum are the later sections of the small intestine where digestion
and absorption are completed before indigested fractions arepushed into the colon. Due to the anatomical complexity of the
small intestine one cannot easily ﬁnd data on food digestion in
these segments. The pancreatic juice contains a mixture of en-
zymes, proenzymes, protease inhibitors, sodium bicarbonate and
other electrolytes that are secreted in parallel and gradually over
the course of 3e4 h, depending on the meal ingested. The
pancreatic secretions contain a variety of enzymes in their pro-
enzyme forms and include protrypsin, prochymotrypsin, pro-
elastase, procarboxypeptidases, pancreatic lipase and a-amylase in
addition to ribonuclease and deoxyribonuclease (Boivin, Lanspa,
Zinsmeister, Go, & Dimagno, 1990; Keller & Layer, 2005).
Currently, IVD models make use of ill-deﬁned mixtures of pancre-
atin or concoct enzyme mixtures mainly containing trypsin and a-
chymotrypsin. Every day, the human liver produces about 0.6e1.0 L
of bile, which are stored in the gallbladder (Seeley et al., 1992). Bile
acids are steroid acids composed mainly from taurocholic acid,
glycocholic acid, taurochenodeoxycholic acid and glyco-
chenodeoxycholic acid which are equal in concentration (Hofmann,
1999). In addition to enzymes delivered into the lumen, enzymes
located in the epithelial brush border contribute to the further
digestion of food. The brush border enzymes include glycosidases
(dextrinase, glucoamylase), peptidases (aminopeptidase, carboxy-
peptidase, dipeptidase) and phophatases (Holmes & Lobley, 1989).
Altogether, the functions of the auxiliary organs in the fasted and
fed conditions are stimuli responsive and are mainly affected by the
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consumer. Unfortunately, a wide range of enzyme outputs and ac-
tivities (units) are reported due to different focus of the studies;
type of diet (calories), speciﬁc nutrient (lipid, carbohydrate, protein
or minerals) or non-nutrients (pharmaceuticals, drugs etc.) and
physical properties of the meal (Armand et al., 1996; O'Keefe et al.,
2003). Further, there are inconsistencies in data on the pancreatic
enzyme activities due to the differences in biochemical assays used
to characterize these secretions: ranging from use of natural or
synthetic standards such as casein, BAEE, TAME, BTEE, measure-
ment modes (potentiometric, colorimetric, spectrophotometric),
calculation methods up to the deﬁnition of enzymatic units of ac-
tivity. Examples for values found in literature are summarized in
Table 1. Mechanically, the small intestine has a segmented nature of
pushing chyme further down the GI and this segmentation motion
was recently shown to be critical for luminal mixing and mass
transfer (Tharakan et al., 2010).
As denoted, the small intestine is the major site of absorption of
small molecules, which can occur passively through diffusion or
actively through various transporter systems in the gut wall
(Johnson, 2007). Further processing of materials can then take
place within epithelia, e.g. lipid packing into chylomicrons. Transit
time through the small intestine varies according to the diet caloric
density; the rheological/mechanical properties (e.g. viscosity or
gelling) andwith consumer parameters, such as age and health (e.g.
2h for healthy adult and 3h for infant (Blanquet et al., 2004)).
2.4. Large intestinal phase
Undigested and un-absorbed foodstuffs and bodily secretions
transit into the large intestine through the ileocecal valve. In this
last part of the human GI tract, water and electrolytes are re-
absorbed and bacterial fermentation of ﬁber and un-digestible
food components occurs before bulk material is excreted (Moran
& Jackson, 1992). The colon is increasingly recognized for its
milieu of bacteria, fungi, protozoa and archaea and rich metabolic
activity equated to that of the human liver (Nardone &
Malfertheiner, 2011; O'Hara & Shanahan, 2006; Olszewska &
Jagusztyn-Krynicka, 2012; Turnbaugh et al., 2007). Recent studies
of the human colon microbiome have established various links
between nutrition, the microbiome and health with evidence that
microbiomes are affected by age, gender, diet, culture, geography
and various physiological/pathological states (Albenberg & Wu,
2014; D'Argenio et al., 2013; Flint, 2012; Holscher et al., 2015;
Olszewska & Jagusztyn-Krynicka, 2012). Therefore, it is no sur-
prise that the ﬁeld of IVD models of the human colon are also a
vibrant ﬁeld, as reviewed by others (Payne et al., 2012). In essence,
the colon hosts immense bacterial counts in three distinct loci: the
proximal, transverse and distal colon, which vary in their steady
state pH with values of 5.8, 6.2 and 6.8, respectively with transit
times of 12e36h. Metabolically, the microbiome is highly active
with both glycolytic and proteolytic activities noted and about 90%
of fermented indigestible polysaccharides being metabolized into
short-chain fatty acids. In addition, the mucosa lining of the colon is
a major site for passive absorption of small metabolites and close
interactions with the immune system (Clemente, Ursell, Parfrey, &
Knight, 2012).
3. IVD models for speciﬁc populations
3.1. Infants
The functionality of human gastro intestinal tract (GIT) develops
in the ﬁrst year of life with newborns (<28 days of life) and infants
up to six months possessing an immature digestive systemcompared to older infants (>6 months) or the fully mature GI of an
adult (Fig. 1). Moreover, prematurity affects strongly the digestive
capabilities, with decreased GI functionality in preterm babies
compared to full-term newborns (Bruce, 2012; Kelly & Coutts,
2000; Kelly & Newell, 1994; Menard, Monﬁls, & Tremblay, 1995).
In fact, there are various differences between infants and adults
mainly in some digestive enzymes and a relatively elevated gastric
pH (3.5e6.5), as exhaustively reviewed (Abrahamse et al., 2012;
Bourlieu et al., 2014; Nguyen, Bhandari, Cichero, & Prakash,
2015b, 2015a). Brieﬂy, infant digestion process neglects oral phase
due to liquid meals rapidly transiting through the oral cavity
(5e10 s). Small stomach storage capacity, affecting meal frequency,
transit and volume, increases quickly during the ﬁrst month of life
from 10 to 20 mL up to 90e150 mL per meal (Abrahamse et al.,
2012; Bourlieu et al., 2014). Infant fasting gastric pH is less acidic
than of an adult (respectively 4e5 vs. 2 in the fasted state) which
may change gastric proteolysis, as optimal activity of pepsin is
1.5e2.2 (Henderson, Hamosh, Armand, Mehta,& Hamosh, 1998; Li-
Chan & Nakai, 1989; Schlamowitz & Peterson, 1959). Reduced
pepsin secretion in newborns, 10e20% from adult levels, is another
physiological reason explaining the limited gastric proteolysis (15%)
reported for infants (Bourlieu et al., 2014; Dupont et al., 2010a;
2010b; Romano, Giosafatto, Masi, & Mariniello, 2015). Pepsin
secretion increases with postnatal age and is more immature in
preterm infants (Guyton, 1991).
In respect to intestinal digestion, proteolysis in infants has
similar pH and trypsin concentrations as those in the intestine of
adults, whereas chymotrypsins and carboxypeptidases-B just ac-
count for about 10%e60% of the activity found in adults (Edginton&
Fotaki, 2010; Lebenthal & Lee, 1980). Regarding lipid digestion,
gastric lipase activity and output are similar in preterm (Roman
et al., 2007), full-term infants and adults (Armand et al., 1996;
Sarles, Moreau, & Verger, 1992). However, pancreatic lipases do
vary between infants and adults with pancreatic triglyceride lipase
(PTL) being the dominant intestinal lipolytic enzyme in adults
while PTL-related protein 2 and bile salt-stimulated lipase are the
key lipases in infants (Lindquist&Hernell, 2010). In light of the high
fat diet of infants (Hamosh, 2006), human breast milk contains
endogenous lipase (bile salt-stimulated lipase mainly, 3.6e5.3 U/
mL of milk) that compensates for the low amount of pancreatic
lipases (5e10% the concentration found in adults) and low con-
centration of bile salts (50% of adult values) (Lebenthal, Lee, &
Heitlinger, 1983). Regarding carbohydrate digestion, scarce data
suggest low values of pancreatic amylase are found in the GI of
infants aged less than 6 months. Thus, carbohydrate digestion in
infants is believed to be highly facilitated by ingested salivary a-
amylase (at birth average of 10% of the adult level but highly vari-
able (Christian, Edwards, & Weaver, 1999; Sevenhuysen,
Holodinsky, & Dawes, 1984)) or mammary a-amylase. In addition,
reports also indicate the infant GI performs carbohydrate digestion
through lactase, sucrose-isomaltase and glucoamylase (with ac-
tivities of ~50% above that of adults) (Bourlieu et al., 2014; Nguyen,
et al., 2015a).
Another important step in infant GI maturation is colonic
colonization of the infant gut with microbiota, which begins at
birth and is an important player in the maturation and education
of the immune system. Development of the infant microbiota is
characterized by rapid and large changes in microbial abundance,
diversity and composition, until around 3 years of age when the
microbiota becomes adult-like (Matamoros, Gras-Leguen, Le
Vacon, Potel, & de La Cochetiere, 2013). Introduction of solid foods
into the infant diet leads to a marked shift in microbial composi-
tion with an increase in clostridial species and a decrease in Biﬁ-
dobacterium and Enterobacteriaceae. Many factors may inﬂuence
the development of the gut microbiota in infants, such as mode of
Fig. 1. Summary of the developing digestive physiology in the human infant. HGL- Human Gastric Lipase, PTL- pancreatic triglyceride lipase, BSSL-bile salt-stimulated lipase,
PTLRP2- pancreatic triglyceride lipase-related protein 2.
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sumption of antibiotics (Arrieta, Stiemsma, Amenyogbe, Brown, &
Finlay, 2014).
Based on the current physiological knowledge of the infant GI,
various static and dynamic IVD models have been applied by re-
searchers (Blanquet et al., 2004; de Oliveira et al., 2015; Dupont
et al., 2010a; 2010b; Roussel et al., 2016; Shani-Levi et al., 2013).
Yet, the development of a harmonized static infant IVD is needed.
One of the most formidable challenges in this respect is the clear
deﬁnition of the consumer being recreated since digestive param-
eters are highly affected by gestational and postnatal age. For
instance preterm newborns compared to full-terms of same age
have higher gastric pH resulting frommore frequent feeding, lower
pepsin activity (10% of adult activity at four weeks vs. 30% in full-
terms), faster gastric emptying, more limited gallbladder contrac-
tion index, lower concentration of electrolytes in pancreatic ﬂuid,
no amylase secretion and lower global pancreatic activity (Bourlieu
et al., 2014).
To date, several studies have depicted static infant IVD models
applied for studying various aspects of protein and lipid digestion.
These various models are summarized in Table 2. As can be noted,
various discrepancies are found in these models and include dis-
crepancies in gastric pH, ill-deﬁned enzymatic proteolytic activity
of enzymes and large variance in experimental duration. For
example, the enzyme activity was most of the time not checked
experimentally or based on the supplier's general characteristics,
which hampered experiment replication in other laboratory. After
an estimation of the pepsin units per mL of milk, a very large range
of values was observed, ranging from 4 to 18563 U/mL of milk
(Table 2). An in vivo study by Armand et al. (1996) reported an
average postprandial value of 63 U/mL of gastric content/kg of
bodyweight of preterm infants, which would correspond to 425 U/
mL of milk for a term newborn of 4.25 kg and a meal to secretion
ratio of 63:37 v/v. In respect to the intestinal phase, pH was ho-
mogeneous (6.5e7.5), but duration varied largely from 5 to 120 min
and the meal proportion in the total volume varied from 25 up to76%. After an estimation of pancreatin content within eachmodel, a
factor of 30 between the maximum and the minimum values was
found across models, which remains lower than that for pepsin (a
4500 fold difference). Bile salts, arising from a porcine or bovine
bile extract or from puriﬁed bile salts, were estimated to vary by a
factor of 10 across models.
In all models presented in Table 2, no clear deﬁnition of the
infant stage was given, except for Fogleman, Cohen, Sakamoto, and
Allen (2012), who aimed to mimic preterm infant digestion.
Further, there are some dynamic IVD models described in recent
literature (Blanquet et al., 2004; Havenaar et al., 2013; Menard
et al., 1995; Menard et al., 2014; de Oliveira et al., 2015; Roussel
et al., 2016; Shani-Levi et al., 2013). In essence, these models try
to recreate some of the dynamic aspects of digestion, e.g. gastric pH
proﬁles post meal ingestion and gastric emptying rates. One of
these has even been validated against in vivo data of proteolysis
kinetics obtained in piglets (Menard et al., 2014). The TIM model
developed by TNO (Netherlands) was adapted to simulate the GI of
newborns, infants and toddlers (0e1, 1e6, and 6e24months of age,
respectively) after ingestion of various types of food (formula milk,
milk and cereals) and validated for these three age groups against
published pharmacokinetic data on paracetamol (Havenaar et al.,
2013). However, in this study, not all GI parameters applied to
this commercial IVD model have been made publicly available. The
same model has been very recently adapted to mimic, based on
in vivo data, the gastric and small intestinal conditions of infant
from 6 months to 2 years (Roussel et al., 2016). Some dynamic
colonic models have also been developed (Cinquin, Le Blay, Fliss, &
Lacroix, 2004; Cinquin, Le Blay, Fliss, & Lacroix, 2006a, 2006b). The
composition and diversity of the bacterial community, as well as its
metabolism, was found to be well correlated with those found
in vivo in infant feces.
Altogether, infant IVD models are increasing in their applica-
bility to food research, however, the variances and discrepancies
found in current infant IVD model call for future efforts to better
deﬁne a simple, harmonized and consensus infant static IVDmodel,
Table 2
Literature review of the proposed in vitro static models for infant gastro-intestinal digestiona.
References Meal Gastric phase Intestinal phase
pH Duration
(min)
Meal:
secretion
ratio (v/v)
Lipase content (/mL
of meal)
Pepsinb content Pepsinc (U/mL
of meal)
Molar ratio
pepsin /
meal
pH Duration
(min)
Meal:
secretion
ratio (v/v)
Enzyme(s) usedc Pancreatin
equivalent (mg/
mL of meal)
Biled
(mg/mL
of meal)
Chatterton et
al., 2004
Human
milk
2, 3, 3.5,
4, 5 or
6.5
60 99:1 Supernatant of
gastric juice from 2
neonates
e e no duodenal phase
Dupont et al.,
2010a
Puriﬁed
proteins
3 60 85:15 e 22.75 U/mg of
protein
273f 0.0042 6.5 30 76:24 Porcine trypsin: 3.45 U/mg of
protein Bovine chymotrypsin: 0.04
U/mg of protein
5.91f,h 1.32i
Fogleman et
al., 2012
Human
milk
5 120 66:34 42.5 mg 2.5 mg/ml of
milk
7500 0.3317 7 120 40:60 Pancreatin: 2 mg/mL of SDFg 0.63 3.75
Lueamsaisuk
et al., 2014
Lueamsaisuk
et al., 2015
Infant
formula
2, 3.5,
4.5 or
5.5
120 20:50 40 U (Rhizopus
Oryzae lipase)
4.5 mg/ml of
SGFe (800-2500
U/mg)
18563 0.2829 No duodenal phase
Prakash et al.,
2014
Infant
formula
1.5 60 50:50 e 3.2 mg/ml of
SGF
9600 0.1463 7 120 25:75 Pancreatin: 1.6 mg/ml of digesta 3.20 10.00
Wada &
Lonnerdal,
2014, 2015
Defatted
bovine milk
4 15 e e 0.08 mg/mg of
protein
2880f 0.0200 7 5 e Pancreatin: protein ratio of 1:62.5 0.19f e
Dall'Asta et al.,
2015
Human
milk
4.5 35 15:9 e 0.013 mg/ml of
milk
4.0 0.0001 7.5 120 15:20 Porcine pancreatin: 9 mg/mL of SDF 3.60 6.00
(bovine
bile)
N-Guyen
Nguyen et
al., 2015a
Infant
formula
4 as detailed for
Dupont et al.,
2010
Liu et al., 2016 Milk
protein
concentrate
3 60 50:50 e 113.8 U/ml of
SGF
113.8 0.0008 6.5 60 25:75 Bovine trypsin: 8.6 U/ml of SDF 2.46h 4.00i
a Digestions were all conducted at 37 C.
b Unless otherwise stated, pepsin originated from a porcine source.
c When pepsin activity was unknown, an activity of 3000 U/mg was considered.
d Enzyme origin mentioned when available.
e Simulated Gastric Fluid.
f A protein concentration of 12 mg/mL of infant formula or milk was considered.
g Simulated Duodenal Fluid.
h A trypsin activity of 7 U/mg of pancreatin was considered.
i A content of 1 mmol of bile salts / g of bile was considered
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as well as sophisticated dynamic IVD models. All of these should be
developed with a rationale similar to that applied by the infant
formula industry, i.e. focusing on speciﬁc and deﬁned target pop-
ulations such as stage one for 0e3 months, stage 2 for 3e6 months
etc.3.2. Elderly
Elderly nutrition, pharmacology and overall health care have
been identiﬁed as one of the rising global challenges (UN, 2013).
Ageing is typically accompanied by a milieu of changes including
substantiated alterations and deterioration of gut functions, such
as secretion of digestive ﬂuids and enzymes, saliva, GIT contrac-
tions and chyme passage rates (Di Francesco et al., 2005; Feldman,
Cryer, McArthur, Huet, & Lee, 1996; Laugier, Bernard, Berthezene,
& Dupuy, 1991; Nagler & Hershkovich, 2005; Russell et al., 1993;
Salles, 2007; Vellas et al., 1988). Due to the irreversible nature of
the changes in GIT functions, there is a growing need to deepen our
understanding of foods' digestive fate in the elderly GI. This would
facilitate rational design of foods to accommodate elderly physi-
ological capabilities, improve nutrient bioaccessibility and
bioavailability and help combat elderly malnutrition. Despite
comprehensive knowledge on the GI deteriorationwith age and its
ramiﬁcations to elderly malnutrition (Remond et al., 2015), there
are scant IVDmodels of the elderly GI found in literature. Onemost
recent study assessed the antioxidant capacity of a milk protein
matrix in aged women, both in vitro and in vivo (Power-Grant et al.,
2016). However, the target population of the study focused solely
on women in the ages of 50e70. In relation to IVD models recre-
ating elderly digestive conditions, two recent studies have been
identiﬁed to apply in vivo data to the modelling parameters (Denis
et al., 2016; Levi & Lesmes, 2014). The ﬁrst reports the set-up of a
dynamic gastro-intestinal elderly (>70 years old) model based on
commercial bioreactors with details on all the parameters used
and the rationale of their selection (Levi & Lesmes, 2014). The
second, reports an adaptation of the TNO gastrointestinal model
(TIM) to the speciﬁc digestive conditions of the elderly (>65 yearsFig. 2. Summary of the developing diold) and is used to study meat protein dynamic digestion (Denis
et al., 2016). A summary of the digestive conditions applied in
these models are given in Fig. 2, also summarizes conditions of the
elderly population at the colon. Similar to the ﬁeld of infant IVD
modelling, elderly digestion models require not only harmoniza-
tion but also validation and clearer deﬁnition of the elderly being
studied.3.3. Developing IVDs for humans with GI disorders
In light of the centrality of the GI system in human health and
disease, various studies present information on human GI disor-
ders. These are deﬁned as diseases and/or conditions that interfere
with the intake, digestion, and/or absorption of nutrients, causing
various clinical symptoms and are broadly deﬁned as maldigestion.
Physiologically, the spectrum and underlying causes of GI disorders
is immense from such conditions causing discomfort (e.g. lactose
malabsorption) to those compromising health (e.g. pancreatic
insufﬁciency in cystic ﬁbrosis patients). All in all, these conditions
arise from altered GI functions which lead to various effects on the
disintegration, breakdown and uptake of nutrients and conse-
quently on health (H€ogenhauer and Hammer, 2010). Some common
factors that interfere with food digestion and related disorders,
infections and surgical procedures linked to them are summarized
in Table 3. In respect to food breakdown and bioaccessibility, many
of the situations described may be mirrored using IVD models, as
such conditions have been found to arise from variance and ab-
normalities in digestive parameters such as changes in gastric/in-
testinal pH, secretion of digestive juices and transit times. Other
disorders such as food allergies, autoimmune disorders (celiac
sprue), Crohn's disease, obesity or diabetes are linked to in-
terferences with the absorption and/or metabolism of nutrients
from the food (Nolan, Johnston,&Walters, 2012), hence IVDmodels
for such conditions require much more sophistication in their
in vitro recreation, if at all feasible. Yet, efforts to develop IVD
models for speciﬁc strata of the populationwould offer useful tools
not only in the development of new tailored foods but also
improving relevant nutritional guidelines.gestive physiology in the elderly.
Table 3
Factors interfering with food digestion and related disorders.
Causes of maldigestion Related diseases Impact
Digestive enzyme deﬁciency Chronic pancreatitis, cystic ﬁbrosis, pancreatic carcinoma Hydrolysis of proteins, carbohydrates and fats
Digestive enzyme inactivation by excess of HCl Zollinger-Ellison syndrome
Dissynchrony of enzyme release and inadequate
mixing
Hyperthyroidism, post billroth ii procedure
(gastrojejunostomy),
gastric bypass
Diminished bile salt synthesis Cirrhosis Fat solubilisation Fat soluble vitamins
absorptionImpaired bile secretion Cystic ﬁbrosis, chronic cholestasis
Increased bile salt loss Ileal disease or resection
Bile salt de-conjugation Bacterial: overgrowth
Bacterial consumption of nutrients Bacterial overgrowth associated to B12 deﬁciency Bioavailability of speciﬁc nutrients
Reduced gastric acid Atrophic gastritis associated to B12 deﬁciency
Reduced intrinsic factor Pernicious anemia associated to B12 deﬁciency
Cofactors deﬁciency Gastric surgery
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community of Cystic Fibrosis (CF) patients that has over 35,000
cases registered in Europe (Colombo & Littlewood, 2011). At least
85% of CF patients have pancreatic insufﬁciency, resulting in fat
malabsorption and binding patients to the use of pancreatic
enzyme supplements. Armand et al. (2004) studied the effect of
diet on gastric lipase levels and fat digestion in childrenwith CF and
reported that gastric lipase was high in cystic ﬁbrosis patients
maintained on fat-rich diets (Armand et al., 2004). Further, Gelfond,
Ma, Semler, and Borowitz (2013) measured the intestinal pH and GI
transit proﬁles in CF patients (Gelfond et al., 2013). Based on this
and other in vivo reports, the development of an IVD model of a CF
patient need to focus on the unique secretion of pancreatic ﬂuid
and bile, both critical parameters in lipid digestion. Analytical
studies show a 3.8-fold higher content of glycoconjugates than
tauroconjugates in human aspirates (Brodlie et al., 2015). Thus,
artiﬁcial bile should reﬂect composition and imbalances between
tauro- and glycol-conjugates isomers and bile concentration should
be low to reﬂect the decreased bile secretion (1 mM). In respect to
enzymatic activity, CF patients are pancreatic insufﬁcient when
pancreas function is below 10% than that of a healthy adult. Then,
the pancreatine activity in a CF model should be 10-fold lower than
that considered in healthy adults.
Another potential IVD model to be developed is that of Gastric
Bypass (GBP) patients (bariatric surgery patients). GBP surgery is
one of the most common and effective treatments for morbid
obesity but can also be used to address conditions such as type 2
diabetes or hypertension. Available physiological literature data on
the digestive process are limited to indirect, with postprandial
serum or urine measurements or scintigraphy evaluation of gastric
emptying. Gastric emptying is reported to be very rapid for liquids,
based on D-xylose in serum, from 18.6 ± 6.9 min prior to GBP to
7.9 ± 2.7 min after GBP (Wang et al., 2012). Extremely rapid pouch
emptying was reported for water vs. whey proteins vs. olive oil as
preloads (30 min) for a liquid glucose drink (t50 3.8 ± 0.9 vs.
4.1 ± 0.6 vs. 3.6 ± 0.5 min, respectively) and for a solid beef patty
meal (1.6 ± 0.7 vs. 1.1 ± 0.6 vs. 1.3 ± 0.5 min, respectively) (Nguyen
et al., 2016). Bojsen-Moller et al. (2015) observed accelerated
caseinate digestion and amino acid absorption (C13 leucine),
resulting in faster and higher but more transient postprandial
elevation of plasma amino acids. Overall, the incidence of a
dumping syndrome, deﬁned as a rapid gastric emptying, is also
elevated after GBP (Horowitz, Collins, Harding, & Shearman, 1985).
Sleeve Gastrectomy (SG), whereby the stomach duodenum
connection remains intact but the volume of the stomach is dras-
tically reduced, has been also been used as an option for surgical
treatment of obesity. In such patients, gastric emptying half times
(t50) were reported to be drastically reduced for both liquids and
solids food (SG vs. control group: 34.9 ± 24.6 vs. 13.6 ± 11.9 min forwater and 78 ± 15.01 vs. 38.3 ± 18.77min for solids [egg sandwich])
(Horowitz et al., 1985). The growing body of evidence on the
ramiﬁcations of GBP procedures on GI function could enable the
development of a relevant IVD model. Such a model would require
a short gastric phase between 30 and 60 min, probably coupled
with a higher pH of 3.5e4.0 compared to the pH 3.0 used in an adult
IVD model. However, without luminal data, only estimates are
possible. Yet, a comprehensive effort should be done to mine the
literature or conduct in vivo experiments to determine enzymatic
activity of pepsin and pancreatic enzymes as well as bile
compositions.
The examples of CF and GBP patients are only two possibilities
for novel IVD models that can be developed and subsequently
validated. Other GI conditions and abnormalities can be recreated
in IVD models pending relevant in vivo data is collected or found in
scientiﬁc literature. These stress out the potential of expanding the
horizons of IVD models based on the rationale exploitation of
medical research.
4. Conclusion
The current modern food production system is complex, dy-
namic and constantly strives to fabricate safe and nutritious food
products and solutions. Amongst the various efforts, researchers
and manufacturers seek to rationally process, structure and
formulate foods towards healthier outcomes for the consumer.
These include development of food delivery systems for protection
of bioactives ingredients added to food, controlling and targeting
their release in the human gastrointestinal tract and affecting
various dimensions of consumer well-being, e.g. shaping the colon
microbiome or inducing satiety and satiation. All of these efforts
rely on understanding the underlying principles guiding food's
digestive fate. An understanding, which can be signiﬁcantly
advanced thanks to the soaring number of studies using in vitro and
in vivo digestion models.
As part of the food-health revolution and evolution of food
manufacturing towards tailored and personalized foods, the po-
tential of IVD models could be maximized when extended to
recreate various strata of the human population. The development
of IVDmodels should rely on better and extensive understanding of
in vivo digestion conditions in different groups of the population
but would offer better opportunities to develop relevant products
with high bioefﬁcacy. Evidently, such novel tools for food and
nutritional research would necessitate adequate standardization
and validation to ensure synchronization of efforts and success.
Such efforts would also greatly beneﬁt from the deposition and
gathering of relevant information in a database where food and
health care professionals could upload in vivo data or in vivo in vitro
correlations and put together pieces of puzzles needed in the
C. Shani-Levi et al. / Trends in Food Science & Technology 60 (2017) 52e63 61development of new IVD models. In light of the concern over rising
prevalence of chronic diseases and challenges in feeding the world,
nutritional management of health and disease prevention are
challenges at the footsteps of dedicated professionals. The authors
of this paper hope that it will stimulate relevant progress in the
ﬁeld and help orchestrate global efforts towards the shared goal of
advancing food science and technology.
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